Picture of Ernexa Therapeutics logo

ERNA — Ernexa Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Eterna Therapeutics Enters Into License & Collaboration Agreement With Factor Bioscience

Sept 27 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS INC:  ON SEPT 24 CO ENTERED INTO
LICENSE &
COLLABORATION AGREEMENT EFFECTIVE  SEPT 9, 2024, WITH FACTOR
BIOSCIENCE LIMITED

Source text for Eikon:  ID:n0001493152-24-038532 
Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ernexa Therapeutics

See all news